Aureka Biotechnologies
Builds biological foundation models and closed-loop infrastructure for drug discovery
$100MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Builds biological foundation models and closed-loop infrastructure for drug discovery
Develops next-generation T-cell engager therapies for cancer and autoimmune diseases